Neurofeedback News
Excellent Brain Ltd. Launches New Android Version for Neurofeedback for ADHD Platform -
Excellent Brain Ltd., a pioneering Israeli start-up in the field of neurofeedback solutions, is proud to announce the launch of its new Android version for the Neurofeedback for ADHD platform. This ...
Neurofeedback game helps patients with MS manage fatigue -
A compassionate neurofeedback game that can identify fatigue aims to help patients with MS, according to a poster presented at Cedars-Sinai’s eighth annual iteration of its Virtual Medicine Conference ...
What is neurofeedback? Video game-like therapy being used to treat anxiety, ADHD and more -
It’s like a gym for your brain. As issues like anxiety, depression and restless sleep have spiked during the pandemic, some people are turning to neurofeedback, a kind of gym for the brain. It’s a ...
Evidence-based retraining of the brain available on the Kenai Peninsula -
Neurofeedback therapy for children and adults offers an effective, alternative to traditional treatment For many people struggling with ADHD, poor focus, insomnia or emotional dysregulation, the path ...
Neurofeedback is the newest mental health hack among entrepreneurs. Here’s why -
Running a business can be an exhilarating and rewarding journey, but it can also bring a unique set of stressors. While the beginning stages of a business can be exciting and feel full of ...
Medical News Today
PubMed
The small molecule simufilam dose-dependently attenuates the worsening of seizures in a mouse model of tuberous sclerosis complex -
OBJECTIVE: Novel epilepsy treatments for patients with tuberous sclerosis complex (TSC) and focal cortical dysplasia type II (FCDII) are urgently needed. In these patients, mutations in the mechanistic target of rapamycin (mTOR) pathway genes lead to mTOR hyperactivity and focal cortical malformations that frequently cause intractable epilepsy and neurological sequelae. Recent evidence suggests...
Death in Epilepsy: Ictogenic Vs. Cardiogenic Mechanisms and Immunoassays in Postmortem Interval Estimation - Case Report -
CONCLUSIONS: This case highlights the important role played by medico-legal autopsy in death investigation in epilepsy. If for legal purpose causality is required, causes of death and conditioning factors are to be extensively investigated and connected. ELISA delivered benchmarks references at 36.8-hour postmortem interval and provided to be a valuable immunoassay method in estimation of postm...
Epilepsy: Molecular Pathogenesis and Emerging Therapies -
Epilepsy is a prevalent and often severe neurological disorder with significant economic and societal impacts. Despite adequate trials with two or more antiseizure medications (ASMs), approximately one-third of patients continue to experience drug-resistant epilepsy. Surgery remains the most effective treatment for patients with drug-resistant focal epilepsy, yet it may be underutilized. Given ...
Hemorrhage Accompanying Psychogenic Nonepileptic Seizure During Cesarean Section: A Case Report -
CONCLUSION: PNES are an important differential diagnosis for perioperative convulsive seizures. Patients often suffer from anxiety, depression or other mental disorders or stress. During an attack, it is often manifested as involuntary left and right swaying of the head and upper limbs, without loss of consciousness.
PURA-Related Neurodevelopmental Disorder: A Comprehensive Clinical Review of Genetics, Phenotype, and Emerging Therapeutic Strategies -
PURA-related neurodevelopmental disorder (PURA-NDD) is an ultra-rare genetic condition caused by heterozygous pathogenic variants in the PURA gene, leading to haploinsufficiency of the Pur-α protein, a critical regulator of neuronal development and RNA trafficking. The disorder is characterized by neonatal hypotonia, global developmental delay, intellectual disability, severely impaired speech,...
Lilii bulbus Exerts Anti-Seizure Effects by Modulating GABAergic Synapse Organization in the Pentylenetetrazol Kindling Model -
Background: We investigated whether a water extract of Lilii bulbus (Lilium lancifolium Thunberg; WELB) could modulate inhibitory synaptic organization in a mouse model of pentylenetetrazol (PTZ)-induced kindling. Methods: Starting 14 days prior to the initial PTZ challenge, WELB (500 mg/kg) was delivered via oral gavage once daily. This treatment regimen was maintained for a total of 40 days, ...
Science Daily